Major Growth Boosting Factors: The growing patient preference for non-invasive and minimally invasive surgical treatments, increasing target patient population, and procedural benefits offered by bone stimulation devices in bone fracture treatments are some key factors propelling the growth of the Bone Growth Stimulator Market.

However, limited medical reimbursement for bone stimulation products and high treatment costs associated with BMP and PRP products may hinder the growth of this market during the forecast period.Revenue Growth Opportunities: The Global Bone Growth Stimulator Market is estimated to reach USD 1.41 billion, at a CAGR of 5.4% during the forecast period.Procedural benefits offered by bone stimulation devices in bone fracture treatment;Bone growth stimulation devices offer a cost-effective and safer alternative mode to treat orthopedic diseases as compared to traditional surgical therapies for nonunion bone fractures.

This is expected to aid the adoption of bone growth stimulation products among key end users.

This is also augmented by clinical evidence that validates the clinical efficacy of bone growth stimulation products in the effective and rapid bone regeneration as compared to traditional methodologies.As of 2015, the average treatment cost saving for diabetes patients in the U.S. being treated with electrical bone growth stimulation (EBGS) devices was reported to be ~USD 4,800 and USD 3,000 as compared to non-stimulation based treatment and low-intensity pulsed Ultrasound stimulation (LIPUS) treatment, respectively (Source: Journal of Diabetes & Metabolism, 2013).

Similarly, a research study was undertaken among adult patients diagnosed with a nonunion bone fracture between July 2006 and September 2009 in the U.S.

This research study estimates the per patient healthcare expenditure for nonunion fractures treatment with EBGS devices to be USD 21,632 as compared to USD 23,843 and USD 23,964 for non-stimulation based treatment and LIPUS treatment, respectively (Source: Orthopedic Research and Reviews, 2013).

According to the new market research report “Bone Growth Stimulator Market by Product (Device, Bone morphogenetic protein, PRP), Application (spinal fusion, Delayed Union & Non Union Bone Fracture, Dental, Maxillofacial), End User (Hospitals, Home care, Academia, CROs) - Global Forecast”, published by MarketsandMarkets™.Bone growth stimulation devices offer a cost-effective and safer alternative mode to treat orthopedic diseases as compared to traditional surgical therapies for nonunion bone fractures.

These devices have been reported to shorten the patient’s hospital stay as well as lessen the risks of complications and infections.

The global Bone Growth Stimulator market is expected to reach USD 1.41 billion, at a CAGR of 5.4%Please share your specific interest to serve you better.https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=82341383Major Driving Factors For Market: Growing patient preference for noninvasive and minimally invasive surgical treatmentsIncreasing Target Patient PopulationProcedural Benefits Offered By Bone Stimulation Devices in Bone Fracture TreatmentBone growth stimulators include the medical devices (external and internal bone growth stimulators) and biologics (PRP and BMP); that are used during or post or after orthopedic treatments related to bone regeneration (including spine fusion surgery, bone fractures, and bone grafts, among others) in order to enhance the bone healing process.Browse and in-depth TOC on "Bone Growth Stimulator Market" 66 - Tables67 - Figures 153 - Pages Bone Growth Stimulator Market, by Product Bone Growth Stimulation DevicesExternal Bone Growth StimulatorsCombined Magnetic Field (CMF) DevicesCapacitive Coupling (CC) DevicesPulsed Electromagnetic Field (PEMF) DevicesImplanted Bone Growth StimulatorsUltrasonic Bone Growth StimulatorsBone Morphogenetic Proteins (BMP)Platelet-rich Plasma (PRP)Request for Sample Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=82341383Bone Growth Stimulator Market, by Application:- Spinal Fusion SurgeriesDelayed Union & Nonunion Bone FracturesOral and Maxillofacial SurgeriesOther ApplicationsOrthofix International N.V. (U.S.), Medtronic plc (Ireland), and Zimmer Biomet Holdings, Inc. (U.S.) are some of the key players in the market.On the basis of region, this market is classified into North America, Europe, Asia-Pacific, and the Rest of the World.

the global bone growth stimulators market was dominated by North America mainly due to the growing elderly population, increasing incidence of arthritis and sports injuries, adoption of novel treatment options, and rising demand for minimally invasive spinal surgeries. 

According to the new market research report "Bone Growth Stimulator Market by Product (Device (Implant, External), Bone Morphogenetic Protein, PRP), Application (Spinal Fusion, Delayed Union, Non-union Bone Fracture, Maxillofacial Surgery), Care Setting (Hospital, Homecare) - Global Forecasts to 2026", published by MarketsandMarkets™, the global market is projected to reach USD 1.5 billion by 2026 from USD 1.1 billion in 2021, at a CAGR of 5.8% during the forecast period.Browse and in-depth TOC on "Bone Growth Stimulator Market"146 - Tables43 - Figures218 - PagesDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=82341383The Rise in the global incidence of AKI and increase in the demand for effective renal replacement therapy among ICU patients and initiatives undertaken by governments to increase the awareness about BGS therapy along with the increase in the launch of advanced BGS system area anticipated to fuel the BGS market growth during the forecast period.The BGS market includes major Tier I and II suppliers of CRRT products are are Orthofix Medical, Inc. (US), DJO Finance, LLC (US), Zimmer Biomet (US), Bioventus LLC (US), Medtronic plc (Ireland), Stryker (US), DePuy Synthes (US), Arthrex, Inc. (US), Isto Biologics (US), Terumo Corporation (Japan), Ember Therapeutics, Inc. (US), Ossatec Benelux Ltd. (Netherlands), Altis Biologics (Pty) Ltd. (South Africa), Regen Lab SA (Switzerland), ITO Co., Ltd. (Japan), Elizur Corporation (US), BTT Health GmbH (Germany), Stimulate Health Inc. (Canada), VQ OrthoCare (US), Kinex Medical Company, LLC (US), Fintek Bio-Electric Inc. (Canada), Biomedical Tissue Technologies Pty Ltd. (Germany), T-Biotechnology (Turkey), DrPRP America LLC (US), Ivy Sports Medicine, LLC (US), Glofinn Oy (Finland), and REMI GROUP (India).These suppliers have their manufacturing facilities spread across regions such as North America and Europe.

The growing patient preference for non-invasive and minimally invasive surgical treatments, the rising prevalence of target conditions, and the growing number of sports and accident-related orthopedic injuries are the key factors driving the growth of the bone growth stimulators market.

However, limited medical reimbursement for bone stimulation devices, high treatment costs associated with BMP and PRP products, and side effects associated with BMP-based orthopedic treatment are the key factors restraining the growth of this market.The growing demand for orthopedic injuries to support the market growth during the forecast period.”The significant rise in demand for BGS in the treatment of orthopedic patients.

Furthermore, many companies are expanding their BGS (PRP products) product portfolios.

For instance, in 2021, Orthofix entered into an exclusive license agreement to commercialize the innovative portfolio of IGEA’s bone, cartilage, and soft tissue stimulation products in the US and Canada.Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=82341383Asia Pacific likely to emerge as the fastest-growing BGS market, globallyGeographically, the emerging Asian countries, such as China, India, Japan and Singapore, are offering high-growth opportunities for Bone Growth Stimulator Market players.

Expansion of healthcare infrastructure and increase in disposable personal income, increase patient population with orthopedic disease, are factors likely to support the growth of market in the region.The prominent players operating in the global Bone Growth Stimulator Market include Orthofix Medical, Inc. (US), DJO Finance, LLC (US), Zimmer Biomet (US), Bioventus LLC (US), Medtronic plc (Ireland), Stryker (US), DePuy Synthes (US), Arthrex, Inc. (US), Isto Biologics (US), Terumo Corporation (Japan), Ember Therapeutics, Inc. (US), Ossatec Benelux Ltd. (Netherlands), Altis Biologics (Pty) Ltd. (South Africa), Regen Lab SA (Switzerland), ITO Co., Ltd. (Japan), Elizur Corporation (US), BTT Health GmbH (Germany), Stimulate Health Inc. (Canada), VQ OrthoCare (US), Kinex Medical Company, LLC (US), Fintek Bio-Electric Inc. (Canada), Biomedical Tissue Technologies Pty Ltd. (Germany), T-Biotechnology (Turkey), DrPRP America LLC (US), Ivy Sports Medicine, LLC (US), Glofinn Oy (Finland), and REMI GROUP (India) among others.Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=82341383Browse Adjacent Markets @ Medical Devices Market Research Reports & ConsultingBrowse Related Reports:Orthopedic Braces & Supports Market by Product (Knee, Ankle, Hip, Spine, Shoulder, Neck, Elbow, Hand, Wrist), Category (Soft, Hard, Hinged), Application (Ligament (ACL, LCL), Preventive, OA), Distribution (Hospital) & Region - Global Forecast to 2025https://www.marketsandmarkets.com/Market-Reports/orthopedic-braces-support-market-24806829.htmlFoot and Ankle Devices Market by Product (Implants, Plates, Screw, Wires, Internal Fixators, Braces, Prosthesis (SACH, Single/Multi-Axial)), Application (Rheumatoid Arthritis, Osteoporosis, Hammertoe), End-User (Hospital, ASCs) - Global Forecasts to 2025https://www.marketsandmarkets.com/Market-Reports/foot-ankle-devices-market-845.htmlAbout MarketsandMarkets™MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues.

According to the new market research report “Bone Growth Stimulator Market by Product (Device, Bone Morphogenetic Protein, PRP), Application (Spinal Fusion, Delay Union & Non-union Bone Fracture, Oral-maxillofacial), End User (Hospitals, Home Care, Academia, CROs) – Global Forecast” published by MarketsandMarkets™.The Global Bone Growth Stimulator Market is estimated to reach USD 1.41 billion, at a CAGR of 5.4% during the forecast period.Procedural benefits offered by bone stimulation devices in bone fracture treatmentBone growth stimulation devices offer a cost-effective and safer alternative mode to treat orthopedic diseases as compared to traditional surgical therapies for nonunion bone fractures.

This is expected to aid the adoption of bone growth stimulation products among key end users.

This is also augmented by clinical evidence that validates the clinical efficacy of bone growth stimulation products in the effective and rapid bone regeneration as compared to traditional methodologies.Browse 66 market data tables and 67 figures spread through 153 pages and in-depth TOC | Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=82341383Market Segmentation in Depth:On the basis of product, the global bone growth stimulators market is segmented into bone growth stimulation devices, bone morphogenetic protein (BMPs), and platelet-rich plasma (PRP).

This large share is attributed to the growing aging population, rising preference for non-surgical treatment procedures, and growing prevalence of nonunion fractures.

Additionally, the rising incidence of obesity, smoking, and diabetes which delay or inhibit bone healing after surgery or trauma are further driving the market growth.On the basis of application, the global bone growth stimulators market is segmented into spinal fusion surgeries, delayed union and nonunion bone fractures, oral and maxillofacial surgeries, and other applications.

The large share of this segment is attributed to the growing geriatric population, rising number of spine procedures (and rate of spinal fusion failure), established safety and efficacy of stimulators in fusion surgery, and increasing use of bone growth stimulation products.Major Market Developments:In 2017, Orthofix International N.V. received CE and FDA approval for its next-generation bone growth stimulators, namely, Cervical-Stim and Spinal- Stim.

The report “Bone Growth Stimulators Market by Product (Device, Bone morphogenetic protein, PRP), Application (spinal fusion, Delayed Union & Non Union Bone Fracture, Dental, Maxillofacial), End User (Hospitals, Home care, Academia, CROs) – Global Forecast”, is expected to reach USD 1.41 billion, growing at a CAGR of 5.4%.Procedural benefits offered by bone stimulation devices in bone fracture treatment;Bone growth stimulation devices offer a cost-effective and safer alternative mode to treat orthopedic diseases as compared to traditional surgical therapies for nonunion bone fractures.

This is expected to aid the adoption of bone growth stimulation products among key end users.

This is also augmented by clinical evidence that validates the clinical efficacy of bone growth stimulation products in the effective and rapid bone regeneration as compared to traditional methodologies.As of 2015, the average treatment cost saving for diabetes patients in the U.S. being treated with electrical bone growth stimulation (EBGS) devices was reported to be ~USD 4,800 and USD 3,000 as compared to non-stimulation based treatment and low-intensity pulsed Ultrasound stimulation (LIPUS) treatment, respectively (Source: Journal of Diabetes & Metabolism, 2013).

Similarly, a research study was undertaken among adult patients diagnosed with a nonunion bone fracture between July 2006 and September 2009 in the U.S.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=82341383The growing patient preference for non-invasive and minimally invasive surgical treatments, increasing target patient population, and procedural benefits offered by bone stimulation devices in bone fracture treatments are some key factors propelling the growth of this market.

However, limited medical reimbursement for bone stimulation products and high treatment costs associated with BMP and PRP products may hinder the growth of this market during the forecast period.Market Segmentation in Detailed:On the basis of product, the global bone growth stimulators market is segmented into bone growth stimulation devices, bone morphogenetic protein (BMPs), and platelet-rich plasma (PRP).

The bone growth stimulation devices segment accounted for the largest share of the market in 2016.

The Research Report Consist of 153 pages, which covers Global Bone Growth Stimulator Market overview, the growing patient preference for non-invasive and minimally invasive surgical treatments, increasing target patient population, and procedural benefits offered by bone stimulation devices in bone fracture treatments are some key factors propelling the growth of this market.The key players focused on various strategies such as product launches and enhancements; agreements & partnerships; strategic acquisitions; and market expansions to increase their shares in the global market.

Product launches & geographical expansions are the strategy adopted by major industry players to achieve desired market growthThe Global Bone Growth Stimulator Market is estimated to reach USD 1.41 billion, at a CAGR of 5.4% during the forecast period.Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=82341383Procedural benefits offered by bone stimulation devices in bone fracture treatment Bone growth stimulation devices offer a cost-effective and safer alternative mode to treat orthopedic diseases as compared to traditional surgical therapies for nonunion bone fractures.

This is also augmented by clinical evidence that validates the clinical efficacy of bone growth stimulation products in the effective and rapid bone regeneration as compared to traditional methodologies.Critical questions the report answers: What are the key growth strategies adopted by major global players to strengthen their market position across emerging and established regions?Greater clinical applications of PRP kits for early orthopedic recovery is an emerging market trend.

What revenue impact will it have in the coming years on the overall bone growth stimulator industry?Emerging countries have immense opportunities for the growth of bone growth stimulators, will this scenario continue?Major Bone Growth Stimulator Market Developments: In 2017, Orthofix International N.V. received CE and FDA approval for its next-generation bone growth stimulators, namely, Cervical-Stim and Spinal- Stim.

These devices are used to stimulate and enhance natural healing process of the body post spinal fusion operation.In 2016, Bioventus LLC, launched its Ultrasound Bone Healing System, EXOGEN in Saudi Arabia.

The product is used in the treatment of delayed unions, non-unions, and joint fusionIn 2015, Zimmer Holdings merged with Biomet, Inc., a U.S.-based company engaged in the development of musculoskeletal medical products.

According to the new market research report “Bone Growth Stimulator Market by Product (Device (Implant, External), Bone Morphogenetic Protein, PRP), Application (Spinal Fusion, Delayed Union, Non-union Bone Fracture, Maxillofacial Surgery), Care Setting (Hospital, Homecare) – Global Forecasts to 2026″, published by MarketsandMarkets™, the global BGS Market is projected to reach USD 1.5 billion by 2026 from USD 1.1 billion in 2021, at a CAGR of 5.8% during the forecast period.Opportunity: Emerging markets;Emerging economies (such as China, India, Brazil, and Mexico) are expected to offer significant growth opportunities in the bone growth stimulators market.

Factors such as the presence of a large patient population, rising healthcare expenditure, government initiatives to support the healthcare industry, strengthening export trade, and growing awareness among physicians, surgeons, and patients about the latest treatment options for spinal fusion and bone healing are expected to boost the demand for bone growth stimulation products in these countries.

In addition, owing to the significant cost advantages, many patients from developed markets are reported to travel to these emerging markets to undergo medical treatment.Emerging economies (such as China, India, Brazil, and Mexico) are expected to offer significant growth opportunities in the bone growth stimulators market.

In addition, owing to the significant cost advantages, many patients from developed markets are reported to travel to these emerging markets to undergo medical treatment.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=82341383The Rise in the global incidence of AKI and increase in the demand for effective renal replacement therapy among ICU patients and initiatives undertaken by governments to increase the awareness about BGS therapy along with the increase in the launch of advanced BGS system area anticipated to fuel the BGS market growth during the forecast period.The growing demand for orthopedic injuries to support the market growth during the forecast period.The significant rise in demand for BGS in the treatment of orthopedic patients.

Moreover, the development and commercialization of BGS products also support Bone Growth Stimulator Market growth.

Furthermore, many companies are expanding their BGS (PRP products) product portfolios.

According to the new market research report “Bone Growth Stimulator Market by Product (Device, Bone morphogenetic protein, PRP), Application (spinal fusion, Delayed Union & Non Union Bone Fracture, Dental, Maxillofacial), End User (Hospitals, Homecare, Academia, CROs) — Global Forecast” , published by MarketsandMarkets™, The Bone Growth Stimulator Market is expected to reach USD 1.41 billion, at a CAGR of 5.4%.On the basis of product, the global bone growth stimulator market is segmented into bone growth stimulation devices, bone morphogenetic protein (BMPs), and platelet-rich plasma (PRP).

The bone growth stimulation devices segment accounted for the largest share of the market.

This large share is attributed to the growing aging population, rising preference for non-surgical treatment procedures, and growing prevalence of nonunion fractures.

Additionally, the rising incidence of obesity, smoking, and diabetes which delay or inhibit bone healing after surgery or trauma are further driving the market growth.Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=82341383On the basis of application, the global bone growth stimulator market is segmented into spinal fusion surgeries, delayed union and nonunion bone fractures, oral and maxillofacial surgeries, and other applications.

The spinal fusion surgeries segment accounted for the largest share of the market.

The large share of this segment is attributed to the growing geriatric population, rising number of spine procedures (and rate of spinal fusion failure), established safety and efficacy of stimulators in fusion surgery, and increasing use of bone growth stimulation products.Browse and in-depth TOC on “Bone Growth Stimulator Market”66 — Tables67 — Figures153 — PagesOn the basis of the end user, the global bone growth stimulator market is segmented into hospitals & clinics, home care, and academic & research institutes and CROs.

The Global Bone Growth Stimulator Market is estimated to reach USD 1.41 billion, at a CAGR of 5.4% during the forecast period.The growing patient preference for non-invasive and minimally invasive surgical treatments, increasing target patient population, and procedural benefits offered by bone stimulation devices in bone fracture treatments are some key factors propelling the growth of this market.Hospitals and Clinics Form the Fastest Growing End User Segment.Hospitals;This segment includes both government and private hospitals that provide treatment or conduct surgeries related to spine, oral and maxillofacial, nonunion/delayed union fractures and dental practices.

An increasing patient population, rising procedural volumes of spinal fusion surgeries, growing prevalence of spinal disorders, and growing awareness on bone growth stimulation products are aiding the growth of this segment.Home care;Home care end users segment include patients who use external bone growth stimulators based on a physician’s prescription.

Physicians recommend these stimulators to patients who have undergone spinal fusion surgery or are suffering from bone fractures that have failed to heal in the normal period of time (delayed or nonunion fracture).

This segment is expected to witness growth due to rising physician preference for bone growth stimulators over their counterparts, cost-effectiveness of external stimulators in the case of nonunion fractures, government recommendations for the use of external stimulators, and the availability of reimbursement and insurance coverageBrowse 66 market data tables and 67 figures spread through 153 pages and in-depth TOC – Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=82341383Market Segmentation in Depth:On the basis of product, the global bone growth stimulators market is segmented into bone growth stimulation devices, bone morphogenetic protein (BMPs), and platelet-rich plasma (PRP).

This large share is attributed to the growing aging population, rising preference for non-surgical treatment procedures, and growing prevalence of nonunion fractures.

Additionally, the rising incidence of obesity, smoking, and diabetes which delay or inhibit bone healing after surgery or trauma are further driving the market growth.On the basis of application, the global bone growth stimulators market is segmented into spinal fusion surgeries, delayed union and nonunion bone fractures, oral and maxillofacial surgeries, and other applications.